UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 237

Sortiert nach

Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline

The journal of clinical endocrinology and metabolism, 2015-11, Vol.100 (11), p.3975-4011

2015

Volltextzugriff (PDF)

Screening for familial cancer risk: Focus on breast cancer

Maturitas, 2017-11, Vol.105, p.69-77

2017

Volltextzugriff (PDF)

Pain management in the Ehlers–Danlos syndromes

American journal of medical genetics. Part C, Seminars in medical genetics, 2017-03, Vol.175 (1), p.212-219

2017

Volltextzugriff (PDF)

Progesterone and endometrial cancer

Best practice & research. Clinical obstetrics & gynaecology, 2020-11, Vol.69, p.95-107

Gompel, Anne

2020

Volltextzugriff (PDF)

Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer

Clinical cancer research, 2017-11, Vol.23 (21), p.6516-6528

2017

Volltextzugriff (PDF)

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.895-915

2012

Volltextzugriff (PDF)

International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.308-320

2012

Volltextzugriff (PDF)

The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers

Biochimie, 2011-09, Vol.93 (9), p.1369-1378

2011

Volltextzugriff (PDF)

Hormone and breast cancer

La Presse médicale (1983), 2019-10, Vol.48 (10), p.1085

Gompel, Anne

2019

Volltextzugriff (PDF)

Estrogen on the breast Yin or Yan?

Maturitas, 2019-06, Vol.124, p.120-120

Gompel, Anne

2019

Volltextzugriff (PDF)

Systemic lupus erythematosus

Maturitas, 2019-06, Vol.124, p.122-122

Gompel, Anne

2019

Volltextzugriff (PDF)

Hereditary Angioedema with and Without C1-Inhibitor Deficiency in Postmenopausal Women

Journal of clinical immunology, 2021-01, Vol.41 (1), p.163-170

2021

Volltextzugriff (PDF)

Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients

Annals of allergy, asthma, & immunology, 2013-10, Vol.111 (4), p.290-294

2013

Volltextzugriff (PDF)

First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome

BMC medical genetics, 2017-04, Vol.18 (1), p.44-44, Article 44

2017

Volltextzugriff (PDF)

Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial

Breast cancer research and treatment, 2015-06, Vol.151 (2), p.309-318

2015

Volltextzugriff (PDF)

BRADYKININ RECEPTOR 2 ANTAGONIST (ICATIBANT) FOR HEREDITARY ANGIOEDEMA TYPE III ATTACKS

Annals of allergy, asthma, & immunology, 2009-11, Vol.103 (5), p.448-448

2009

Volltextzugriff (PDF)

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

PloS one, 2009-01, Vol.4 (1), p.e4223-e4223

2009

Volltextzugriff (PDF)

Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue

Breast cancer research and treatment, 2013-11, Vol.142 (2), p.283-296

2013

Volltextzugriff (PDF)

Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice

Oncotarget, 2014-09, Vol.5 (18), p.8235-8251

2014

Volltextzugriff (PDF)

Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice

PloS one, 2014-05, Vol.9 (5), p.e97151

2014

Volltextzugriff (PDF)

Hormones et cancers du sein

La Presse médicale (1983), 2019-10, Vol.48 (10), p.1085-1091

Gompel, Anne

2019

Volltextzugriff (PDF)

Hormone therapy and breast cancer: Is adding progesterone an issue?

Maturitas, 2017-06, Vol.100, p.96-96

Gompel, Anne

2017

Volltextzugriff (PDF)

Menopause hormone treatment after gynecological cancers

Maturitas, 2017-06, Vol.100, p.101-102

Gompel, Anne

2017

Volltextzugriff (PDF)

Expression of neurotensin and NT1 receptor in human breast cancer : A potential role in tumor progression

Cancer research (Chicago, Ill.), 2006-06, Vol.66 (12), p.6243-6249

2006

Volltextzugriff (PDF)

Progestins are Efficient Agents in Estrogen-sensitive Nonhistaminic Angioedema

The American journal of medicine, 2014-10, Vol.127 (10), p.e7-e7

2014

Volltextzugriff (PDF)

1 – 25 von 237

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(203)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline

Screening for familial cancer risk: Focus on breast cancer

Pain management in the Ehlers–Danlos syndromes

Progesterone and endometrial cancer

Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency

The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers

Hormone and breast cancer

Estrogen on the breast Yin or Yan?

Systemic lupus erythematosus

Hereditary Angioedema with and Without C1-Inhibitor Deficiency in Postmenopausal Women

Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients

First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome

Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial

BRADYKININ RECEPTOR 2 ANTAGONIST (ICATIBANT) FOR HEREDITARY ANGIOEDEMA TYPE III ATTACKS

The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression

Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue

Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice

Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice

Hormones et cancers du sein

Hormone therapy and breast cancer: Is adding progesterone an issue?

Menopause hormone treatment after gynecological cancers

Expression of neurotensin and NT1 receptor in human breast cancer : A potential role in tumor progression

Progestins are Efficient Agents in Estrogen-sensitive Nonhistaminic Angioedema

Suchergebnisse filtern